Casdin Capital’s Eli Casdin highlights seven promising life-sciences stocks, including bluebird bio, Invitae, and Crispr Therapeutics.
7 Biotech Stocks to Buy for a Post-Pandemic World
Posted in biotech/medical
Posted in biotech/medical
Casdin Capital’s Eli Casdin highlights seven promising life-sciences stocks, including bluebird bio, Invitae, and Crispr Therapeutics.